Although anti-inflammatory and immunosuppressant drugs such as 6-mercaptopurines, cyclosporine, anti-tumor necrosis factor α (TNF-α) antibody, 5-aminosalicylic acid and corticosteroids are currently available for IBD treatment [4–6], it is difficult to achieve an ideal therapy on IBD. Here, TNF is linked to inflammatory bowel disease.